Vanguard Morgan Growth Fund (VMRGX) is an actively managed open-end mutual fund that seeks long-term capital appreciation by primarily investing in the common stocks of mid- and large-capitalization U.S. companies demonstrating above-average growth potential; the fund allocates across growth-oriented sectors including technology, healthcare, and consumer discretionary, with top holdings typically featuring established names in these areas and secondary exposure to smaller companies sharing similar characteristics. Investor shares (VMRGX) and admiral shares provide access with expense ratios around 0.38%, managed through a multi-manager structure historically involving subadvisors such as Frontier Capital Management, Wellington Management Company, and others prior to realignments. Launched on December 31, 1968, the fund operates under The Vanguard Group, Inc., headquartered in Malvern, Pennsylvania, and primarily targets U.S. individual and institutional investors seeking growth equity exposure. In December 2018, Vanguard announced and completed in early 2019 the merger of the approximately $15.1 billion Vanguard Morgan Growth Fund into the $10.2 billion Vanguard U.S. Growth Fund (VWUSX), retaining the combined entity's focus on large-cap U.S. growth stocks with reasonable valuations, enhanced advisor lineup, and lowered expense ratios for investor shares at 0.38%; this consolidation improved operational efficiencies without altering core investment objectives or strategies. Post-merger, the fund continues active trading as reflected in real-time quotes, performance tracking, and holdings data through 2025, with assets under management previously reported near $8.7 billion and recent share prices around $27.82.